Department of Surgery, Harbor-UCLA Medical Center, Torrance, CA, USA.
Ann Surg Oncol. 2013 Oct;20(10):3266-73. doi: 10.1245/s10434-013-3150-z. Epub 2013 Aug 22.
The benefit of adjuvant radiotherapy (RT) in elderly breast cancer patients is debatable. The purpose of this study was to evaluate trends in RT rates after breast-conserving surgery.
Breast cancer patients ≥70 years treated from 2000 to 2009 were identified using the Surveillance, Epidemiology, and End Results (SEER) database. Patients were estrogen receptor positive with negative or unknown lymph node status. Trends in RT recommendation over years were evaluated with the Jonckheere-Terpstra test. Multiple logistic regression and Cox proportional hazard tests were used to determine factors associated with radiation recommendation and survival.
Of 46,581 patients, 31,989 (68.7 %) were recommended RT and 14,592 (31.3 %) were not. The recommendation for RT decreased from 70.3 % in 2000 to 67.4 % in 2009 (p < 0.0001). Seven of 18 registries exhibited decreased radiation recommendation rates, and 4 of 18 exhibited an increase. Recommendation of RT was associated with earlier year of diagnosis, younger age, Asian/Pacific Islander race, and negative lymph nodes. Predictors of worse survival were no radiation [hazard ratio (HR) 1.68, 95 % confidence interval (CI) 1.61-1.75], no nodes examined (HR 1.83, 95 % CI 1.75-1.91), large (>2-5 cm) tumor size (HR 2.02, 95 % CI 1.86-2.19), older age (80+, HR 2.38, 95 % CI 2.25-2.53), and black race (HR 1.13, 95 % CI1.03-1.23).
Rates of radiation recommendation in the elderly have been steadily decreasing without appreciable acceleration in this decline. This trend was not consistent across all registries. Continued research is necessary to assess differences in clinical practice and its impact on patient outcomes.
辅助放疗(RT)在老年乳腺癌患者中的益处存在争议。本研究的目的是评估保乳手术后 RT 率的趋势。
使用监测、流行病学和最终结果(SEER)数据库确定 2000 年至 2009 年期间治疗的年龄≥70 岁的乳腺癌患者。患者雌激素受体阳性,淋巴结状态为阴性或未知。使用 Jonckheere-Terpstra 检验评估多年来 RT 推荐的趋势。多因素逻辑回归和 Cox 比例风险检验用于确定与辐射推荐和生存相关的因素。
在 46581 名患者中,31989 名(68.7%)被推荐接受 RT,14592 名(31.3%)未接受。RT 推荐率从 2000 年的 70.3%下降到 2009 年的 67.4%(p<0.0001)。18 个登记处中有 7 个的放疗推荐率下降,4 个登记处的放疗推荐率上升。RT 推荐与较早的诊断年份、较年轻的年龄、亚洲/太平洋岛民种族和阴性淋巴结有关。无放疗的生存较差的预测因素为 [风险比(HR)1.68,95%置信区间(CI)1.61-1.75]、无淋巴结检查(HR 1.83,95%CI 1.75-1.91)、较大(>2-5cm)肿瘤大小(HR 2.02,95%CI 1.86-2.19)、年龄较大(80+,HR 2.38,95%CI 2.25-2.53)和黑人种族(HR 1.13,95%CI1.03-1.23)。
在没有明显加速下降的情况下,老年患者接受放疗的比例一直在稳步下降。这种趋势在所有登记处并不一致。需要进一步研究以评估临床实践中的差异及其对患者结局的影响。